The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Open accessAbstract
N 6-methyladenosine (m 6 A) is the most abundant mRNA modification and is catalyzed by the methyltransferase complex, in which methyltransferase-like 3 (METTL3) is the sole catalytic subunit. Accumulating evidence in recent years reveals that METTL3 plays key roles in a variety of cancer types, either dependent or independent on its m 6 A RNA methyltransferase activity. While the roles of m 6 A modifications in cancer have been extensively reviewed elsewhere, the critical functions of METTL3 in various types of cancer, as well as the potential targeting of METTL3 as cancer treatment, have not yet been highlighted. Here we summarize our current understanding both on the oncogenic and tumor-suppressive functions of METTL3, as well as the underlying molecular mechanisms. The well-documented protein structure of the METTL3/METTL14 heterodimer provides the basis for potential therapeutic targeting, which is also discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Lin, X., Chai, G., Wu, Y., Li, J., Chen, F., Liu, J., Luo, G., Tauler, J., Du, J., Lin, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09865-9 · Cited by 510
RetractedJin, D., Guo, J., Wu, Y., Du, J., Yang, L., Wang, X., Di, W., Hu, B., An, J., Kong, L., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0830-6 · Cited by 501
RetractedWang, H., Deng, Q., Lv, Z., Ling, Y., Hou, X., Chen, Z., Dinglin, X., Ma, S., Li, D., Wu, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1108-x · Cited by 215
RetractedZhang, Y., Kang, M., Zhang, B., Meng, F., Song, J. H., Kaneko, H., Shimamoto, F., & Tang, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1116-x · Cited by 140
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558
Cited by
RNA sequencing: new technologies and applications in cancer research
Hong, M., Tao, S., Zhang, L., Diao, L.-T., Huang, X., Huang, S., Xie, S.-J., Xiao, Z.-D., & Zhang, H. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01005-x · Cited by 596
The roles and implications of RNA m6A modification in cancer
Deng, X., Qing, Y., Horne, D., Huang, H., & Chen, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00774-x · Cited by 364
Huang, H., Lin, Y., Xin, J., Sun, N., Zhao, Z., Wang, H., Duan, L., Zhou, Y., Liu, X., Fang, J., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116816 · Cited by 15
Ramage, D. E., Grant, D. W., & Timms, R. T. (2025) · Nature Communications · doi:10.1038/s41467-025-56782-1 · Cited by 6
Metadata
- Authors
- Zeng, C., Huang, W., Li, Y., & Weng, H.
- Venue
- Journal of Hematology & Oncology
- Published
- 2020-08-27
- Volume
- 13
- Issue
- 1
- Pages
- 117-117
- ISSN
- 1756-8722 (ISSN-L)
- OpenAlex
- W3081921226
- Cited by
- 634
- References
- 145
- FWCI
- 19.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Roles of METTL3 in cancer: mechanisms and therapeutic targeting. https://app.cochat.ai/papers/10.1186/s13045-020-00951-w
- The paper
- Zeng, C., Huang, W., Li, Y., & Weng, H. (2020). Roles of METTL3 in cancer: mechanisms and therapeutic targeting. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-020-00951-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.